Aptadir Therapeutics
Latest round
- Seed
Last raised
- Sep 2026
Total raised
- $46M
Investors
- 10
About Aptadir Therapeutics
Founded in 2023 and based in Milan, Italy, Aptadir Therapeutics operates as a biotechnology company that creates RNA-based treatments for illnesses brought on by abnormal DNA methylation., CDP Venture Capital, Angelini Ventures, Kerna Ventures, Italian Angels for Biotech, and Club Degli Investitori. Aptadir Therapeutics offers a range of software solutions designed to improve operations across various industries. The company's offerings include a cloud-based platform that manages project management, collaboration, and workflow automation. The platform allows patients to track common pain points such as communication breakdowns, task tracking, and resource allocation. As of 2024, the firm serves various industries such as technology, healthcare, and finance, with a specific focus on markets in North America and Europe.
Who invested in Aptadir Therapeutics
10 investors across 1 round
See all investors in Aptadir Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 29, 2026
Amount
$46M
Investors
Questions about Aptadir Therapeutics
Who invested in Aptadir Therapeutics?
Aptadir Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aptadir Therapeutics raised?
Aptadir Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aptadir Therapeutics last raise money?
Aptadir Therapeutics's most recent round on record is a Seed, in Sep 2026.
What does Aptadir Therapeutics do?
Founded in 2023 and based in Milan, Italy, Aptadir Therapeutics operates as a biotechnology company that creates RNA-based treatments for illnesses brought on by abnormal DNA methylation.
Where is Aptadir Therapeutics headquartered?
Aptadir Therapeutics is headquartered in Milan, Italy.
Which VCs invest in companies like Aptadir Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Aptadir Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Aptadir Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.